Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$11,695,064
+$336,915 QoQ
Shares Held
46,049
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#1,017
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Telos Capital Management, Inc. holds $41,593,885 across 9 Drug Manufacturers - General names. JNJ ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
46,049 | $11,695,064 | |
| 2 | AMGN |
Amgen Inc
|
25,990 | $9,411,498 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
111,780 | $6,440,763 | |
| 4 | ABBV |
AbbVie Inc.
|
18,380 | $4,625,143 | |
| 5 | NVS |
Novartis AG
|
25,483 | $3,993,695 | |
| 6 | LLY |
ELI LILLY & Co
|
2,302 | $2,761,088 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,035 | $1,803,497 | |
| 8 | PFE |
Pfizer Inc
|
25,954 | $624,972 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,695,064 | 46,049 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $11,358,149 | 46,466 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $9,919,941 | 47,934 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $9,109,499 | 49,129 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,473,446 | 48,926 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $8,036,440 | 48,459 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $7,852,287 | 54,296 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,684,957 | 53,591 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $8,084,401 | 55,312 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $11,000,374 | 69,539 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $11,492,490 | 73,322 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $11,747,443 | 75,425 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $12,442,634 | 75,173 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $11,667,780 | 75,276 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $13,279,133 | 75,172 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $12,393,469 | 75,866 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $12,748,413 | 71,818 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $12,811,247 | 72,286 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $12,847,528 | 75,101 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $11,799,351 | 73,061 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $12,198,667 | 74,048 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $11,829,584 | 71,978 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $11,628,178 | 73,886 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $11,008,336 | 73,941 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $9,725,830 | 69,159 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $8,934,542 | 68,135 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||